id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-7032-0006,FDA,FDA-2017-P-7032,Petition Approval Letter from FDA CDER to Jubilant Generics Limited,Other,Agency Response,2021-08-12T04:00:00Z,2021,8,2021-08-12T04:00:00Z,,2021-08-12T15:30:52Z,,0,0,0900006484c4a80a
FDA-2017-P-7032-0003,FDA,FDA-2017-P-7032,Exhibit 1 Electronic Orange Book re Citizen Petition from Jubilant Generics Limited,Supporting & Related Material,Background Material,2017-12-29T05:00:00Z,2017,12,,,2018-01-02T16:48:54Z,,0,0,0900006482d84ab7
FDA-2017-P-7032-0005,FDA,FDA-2017-P-7032,Exhibit 3 Draft Labeling for proposed product re Citizen Petition from Jubilant Generics Limited,Supporting & Related Material,Background Material,2017-12-29T05:00:00Z,2017,12,,,2018-01-02T16:49:28Z,,0,0,0900006482d84aba
FDA-2017-P-7032-0001,FDA,FDA-2017-P-7032,Citizen Petition from Jubilant Generics Limited,Other,Citizen Petition,2017-12-29T05:00:00Z,2017,12,2017-12-29T05:00:00Z,2018-06-28T03:59:59Z,2018-01-02T16:48:06Z,,0,0,0900006482d843bf
FDA-2017-P-7032-0002,FDA,FDA-2017-P-7032,Acknowledgment Letter from FDA DDM to Jubilant Generics Limited,Other,Acknowledgement Letter/Receipt,2017-12-29T05:00:00Z,2017,12,2017-12-29T05:00:00Z,,2018-01-02T16:48:30Z,,0,0,0900006482d843c1
FDA-2017-P-7032-0004,FDA,FDA-2017-P-7032,Exhibit 2 RLD Labeling re Citizen Petition from Jubilant Generics Limited,Supporting & Related Material,Background Material,2017-12-29T05:00:00Z,2017,12,,,2018-01-02T16:49:10Z,,0,0,0900006482d84ab8